Stockscreener 앱 받기
33.35
0.33%
-0.11
시간 외 거래:
33.35
전일 마감가:
$33.46
열려 있는:
$33.5
하루 거래량:
260.73K
Relative Volume:
0.62
시가총액:
$1.08B
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
28.03
EPS:
1.19
순현금흐름:
$274.29M
1주 성능:
+1.34%
1개월 성능:
+7.93%
6개월 성능:
+4.41%
1년 성능:
+1.86%
1일 변동 폭
$32.91
$33.73
1주일 범위
$32.29
$33.99
52주 변동 폭
$28.39
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
33.35 | 1.08B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Ritholtz Wealth Management Has $968,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Burney Co. Sells 38,157 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $43.80 - Defense World
Collegium pharmaceutical EVP Shirley Kuhlmann sells $908,627 in stock By Investing.com - Investing.com Australia
Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 27,500 Shares of Stock - MarketBeat
Despite the downward trend in earnings at Collegium Pharmaceutical (NASDAQ:COLL) the stock swells 18%, bringing three-year gains to 82% - Simply Wall St
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
JPMorgan Chase & Co. Has $10.71 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Earns Buy Rating from HC Wainwright - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Raised to “Buy” at Needham & Company LLC - Defense World
Collegium Pharma spikes after 2025 outlook - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Needham & Company LLC - MarketBeat
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Collegium Pharmaceutical Unveils 2025 Financial Projections - Yahoo Finance
COLLCollegium Pharmaceutical, Inc. Latest Stock News & Market Updates - StockTitan
Collegium Pharmaceutical (NASDAQ:COLL) Trading 2.8% HigherShould You Buy? - MarketBeat
Collegium Pharma stock spikes on 2025 outlook (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical, Inc. Provides Earnings Guidance for the Year 2025 -January 08, 2025 at 08:00 am EST - Marketscreener.com
Collegium Provides 2025 Financial Guidance and Business Update - GlobeNewswire
Collegium Pharmaceutical Projects Record $750M Revenue in 2025, ADHD Drug Leads Growth - StockTitan
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month LowHere's What Happened - MarketBeat
Collegium stock hits 52-week low at $28.46 amid market challenges - Investing.com Australia
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month LowWhat's Next? - MarketBeat
Franklin Resources Inc. Has $1.16 Million Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Geode Capital Management LLC Has $29.97 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus - Yahoo Finance
Sanctuary Advisors LLC Buys 1,731 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Barclays PLC - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Barclays PLC - Defense World
Collegium Pharmaceutical stock hits 52-week low at $28.75 By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical stock hits 52-week low at $28.75 - Investing.com
Improved Revenues Required Before Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Find Their Feet - Simply Wall St
When the Price of (COLL) Talks, People Listen - Stock Traders Daily
Collegium Pharmaceutical (NASDAQ:COLL) Reaches New 1-Year LowWhat's Next? - MarketBeat
Principal Financial Group Inc. Has $67.46 Million Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Price Target at $42.60 - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Wellington Management Group LLP Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Holdings Lifted by Fmr LLC - Defense World
Fmr LLC Increases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies? - Marketscreener.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.29 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
The Manufacturers Life Insurance Company Sells 816 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Janus Henderson Group PLC Boosts Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com
Loomis Sayles & Co. L P Has $737,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Penserra Capital Management LLC Buys New Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Rubric Capital Management LP Reduces Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $42.60 - Defense World
Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
0.08%
자본화:
|
볼륨(24시간):